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Objectives: The aim of this study was to evaluate the clinical, radiographic and histologic results when a highly purified 
xenogenic bone (Laddec®) was used as grafting material in maxillary sinuses.
Material and Methods: In fifteen patients requiring unilateral maxillary sinus augmentation, the grafting procedure was 
performed with Laddec®. Forty-two implants were installed after a 6 month healing period. The height of the augmented 
sinus was measured radiographically immediately after augmentation and postoperatively up to 36 months. At the time of 
implant placement, a bone core was harvested in each patient for histological examination.
Results: The cumulative implant survival rate was 97.6%. The original height was 3.65 (SD 0.7) mm and the augmented 
sinus height was 13.8 (SD 1.4) mm after the surgery. The reduced height of grafted xenogenic material (RDL) at the implant 
insertion was 0.83 (SD 0.38) mm, and at the final postoperative visit was 0.91 (SD 0.25) mm, showing no significant correlation 
with the follow-up periods by Spearman’s test (P = 0.118). In addition, no significant difference in the RDL was observed 
according to the site of implantation (P = 0.682). The mean implant marginal bone loss was 0.38 (SD 0.24) mm. Histological 
analysis showed the bone cores were composed of 64.72 (SD 3.44)% newly formed bone, 17.41 (SD 2.02)% connective tissue, 
16.93 (SD 2.83)% residual graft particles, and 0.94 (SD 0.11)% inflammatory cells.
Conclusions: According to our data, the highly purified xenogenic bone (Laddec®), used as graft material in the sinus lift 
procedure, may create adequate bone volume, and appropriate osseointegration of dental implants.
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INTRODUCTION
A maxillary sinus lift procedure is an established 
method used to provide a sufficient bone volume 
for implant placement in patients with a severely 
atrophied posterior maxilla [1-3]. The use of 
autogenous bone in sinus augmentation is believed 
to be a superior method because of the repro ducible 
healing mechanism of osteogenesis, osteoinduction, 
and osteoconduction. However, some important 
disadvantages, such as the need for additional 
surgical sites, the associated morbidity, and the rapid 
resorption rate when autogenous bone is used as a 
sinus grafting material [4-6], have led many surgeons 
to use other materials including derived bovine bone 
[7,8]. Graft materials consisting of deproteinized, 
sterilized, bovine bone, are reported by several studies 
to be osteoconductive and well integrated in the host 
site with very low resorbability [9-18].
Recently, a highly purified, bovine bone derived 
graft (Laddec®) has been introduced to clinicians for 
its innovative features. It is a xenograft consisting of 
deproteinized, sterilized bovine bone, characterized 
by the preservation of a collagen type I matrix, 
associated with spindle-shaped hydroxyapatite 
crystals. Unlike other commercially available bovine 
derived biomaterials in which all the organic phase 
is chemically removed using ethylene diamine 
treatment and heating, followed by extensive washing 
and heating below 600 °C (U.S. patent 5,167,961), 
Laddec® is obtained from bovine bone after extensive 
washing with distilled water and a phosphate 
buffer (0.4 M, pH 7.4), followed by defatting at a 
temperature <50 °C with ethanol/dichloromethane and 
proteoglycan removal by urea and mercaptoethanol 
(International patent: PCT/WO/91/07194). This 
process has previously been shown to preserve the 
collagen type I fibres in the matrix of the xenograft 
[7], which seem to play a crucial role in cell 
attachment, as well as the spreading and orientation of 
osteoblasts, as collagen type I can bind osteoblasts via 
specific cell surface receptors, the integrins [19,20]. 
In addition to the maintenance of the collagen fibres, 
Laddec® presents physical characteristics very similar 
to human cancellous bone, with an average thickness 
of trabecules of 164.8 (35.1) µm, an intertrabecular 
separation (porosity) of 342.9 (105.6) µm, and 2 (0.4) 
trabecules per mm [21].
Preclinical studies have already shown the capacity 
of Laddec® to stimulate osteoblastic activity, 
facilitating the formation of multiple cell layers, and 
to increase the expression of alkaline phosphatase in 
mesenchymal cell cultures [20-22].
Furthermore, subsequent clinical and histological 
studies in humans indicated that the processing 
methodology of Laddec® is safe, as the biomaterial 
does not induce Laddec® immunologic response, and 
it represents a reliable option in oral and maxillofacial 
surgery procedures [23,24].
The aim of this study was to evaluate the clinical, 
radiographic and histologic results when highly 
purified xenogenic bone (Laddec®) was used as a 
grafting material in maxillary sinuses.
MATERIAL AND METHODS
Patients
Fifteen patients (8 males and 7 females, aged from 
48 to 66 years, with a mean of 58 [5.2] years), with 
a severely atrophied posterior maxilla, participated 
in this study. This study used a retrospective clinical 
database of information about patients who were 
previously treated as part of an approved research 
protocol (University Ethical Committee approbation 
#7413). All patients signed a written informed 
consensus, and the study was conducted according 
to the principles of the Declaration of Helsinki on 
experimentation involving human subjects.
Inclusion criteria were: 1) presence of maxillary 
partial edentulism involving the premolar/molar 
areas; 2) the presence of a residual alveolar ridge 
height less than 5 mm; 3) patients in which primary 
implant stability could not be established.  Exclusion 
criteria were: 1) smoking more than 10 cigarettes/day; 
2) systemic diseases or maxillary sinus pathology; 3) 
recent extractions in the involved area.
A thorough preoperative evaluation, including the 
studying the mounted diagnostic cast and diagnostic 
wax-up, was performed. Radiograph examination 
included both intraoral and computerized tomography. 
Preoperative medications included amoxicillin, and 
1 g twice a day of clavulanic acid (NeoDuplamox, 
Procter & Gamble), starting 1 day prior to surgery and 
continuing until 8 days post-surgery. Patients were 
asked to rinse with 0.2% chlorhexidine gluconate at the 
surgery and twice a day for 14 days after the procedure. 
Surgical protocol
Under local anaesthesia, a crestal incision was 
made slightly toward the palatal aspect and 
throughout the entire length of the edentulous 
segment, supplemented by buccal releasing 
incisions mesially and distally. Full thickness flaps 
were elevated to expose the alveolar crest and 
the lateral wall of the maxillary sinus (Figure 1). 
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Using a round burr under cold (4 - 5 °C) sterile 
saline irrigation, a trap door was made in the 
lateral sinus wall (Figure 2). The door was rotated 
inward and upward with a top hinge to a horizontal 
position (Figure 3). The sinus membrane was lifted 
with elevator instruments of different shapes until 
it became completely detached from the lateral 
Figure 1. Full thickness flap elevated to expose the alveolar crest 
and the lateral wall of the maxillary sinus.
Figure 2. A trap door made in the lateral sinus wall.
Figure 3. The door was rotated inward and upward with a top hinge 
to a horizontal position.
Figure 4. The Laddec® particles mixed with sterile saline solution 
and carefully packed in the sinus cavity.
Figure 5. A cross-linked collagen membrane positioned against the 
packed sinus window and folded over.
and inferior walls of the sinus. Small tears in the 
membrane were covered with a cross-linked collagen 
membrane (Mem-Lok®, BioHorizons, Birmingam, 
Alabama, USA), before graft placement to avoid the 
possible complication of sinusitis from the migration 
of granules towards the middle meatus with its 
obstruction.
The Laddec® (BioHorizons, Birmingam, Alabama, 
USA) particles were mixed with sterile saline 
solution and carefully packed in the sinus cavity 
using a plugger (Figure 4). The quantity of Laddec® 
needed for each augmentation varied from 3 to 5 g. 
A membrane (Mem-Lok®, BioHorizons, Birmingam, 
Alabama, USA) was positioned against the packed 
sinus window and was folded over (Figure 5). 
The mucoperiosteal flap was then replaced and 
sutured with multiple horizontal mattress sutures 
(Figure 6). Sutures were removed 2 weeks after 
surgery (Figure 7). Postsurgical visits were scheduled 
at monthly intervals to check the course of healing.
The sinus was allowed to heal for 6 months, and then 
Laser-Lok® BioHorizons implants (BioHorizons, 
Birmingam, Alabama, USA) were placed. 
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Radiographic analysis
Radiographic analysis was performed using intraoral 
radiographs and computerized tomography (Figures 
8 and 9). At least 3 computerized topographies 
Figure 7. Sutures removed 2 weeks after surgery.Figure 6. The mucoperiosteal flap replaced and sutured with 
multiple sutures.
were taken, one immedi ately before and one after the 
sinus augmentation, and another one up to 3 years 
after the surgery. Intraoral radiographs were obtained 
every 6 months through the follow-up period. The 
linear measure ments taken from radiographs were 
described below.
Figure 8. Preoperative computerized tomography.
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The original alveolar bone heights prior to the surgery, 
from the alveolar crest to the base of the sinus, were 
measured. The augmented sinus heights (ASH) were 
measured from the 1st bone to implant contact points 
to the base of the maxillary sinus, which had been 
elevated with Laddec® at the mesi al and distal aspects 
of the implants. The marginal bone loss (MBL) was 
determined by comparing the intraoral radiographs 
immediately taken after the surgery and up to 3 years 
after implant loading. The reduced height of Laddec® 
(RDL) was calculated based on the changes in the 
ASH and MBL.
Histologic analysis
At time of the implant surgery, bone cores 
were harvested using a 3.5 x 10 mm diameter 
trephine under cold (4 - 5 °C) sterile saline solution 
irrigation. The bone specimens were immediately 
fixed in 10% buffered formalin and embedded in 
Figure 9. Postoperative computerized tomography.
a glycolmethacrylate resin. After polymerization, 
specimens were sectioned along their longitudinal 
axis to a thickness of 70 microns (Laddec® plastic 
Microtome, RM 2265). Slides were stained with 
trichrome, methilyne blue, and Von Kossa (Figure 10). 
Figure 10. Bone core specimens: A = Trichrome stain; B = 
Von Kossa stain; C = Methylene Blue and Basic Fuschin stain. 
Original magnification x1.25.
A B C
http://www.ejomr.org/JOMR/archives/2016/1/e3/v7n1e3ht.htm J Oral Maxillofac Res 2016 (Jan-Mar) | vol. 7 | No 1 | e3 | p.6
(page number not for citation purposes)
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                              Guarnieri et al.
Slides were examined using an Olympus B51 
microscope. The histomorphometry was performed 
using Bioquant® image analysis software (R&M 
Biometrics, Nashville, TN, USA) and images were 
captured with a Q-Imaging camera, 32-0013B-157, 
RETIGA, Colour 12-bit (Figures 11 and 12).
Statistical analysis
Mean values for all measurements were calculated. 
Differences in RDL according to the timing of 
implantation were analysed using an independent 
t-test. A one-way analysis of variance was used to 
evaluate the differences in RDL according to the 
implant sites. Correlation be tween the RDL and 
follow-up period were determined by Spearman’s 
test. Parametric data were expressed as mean and 
standard deviation (SD). Statistical significance level 
was defined at P = 0.05. SPSS ver. 12.0.0 (SPSS Inc., 
Chicago, IL, USA) was used for all statistical analysis.
A B
Figure 11. Trichrome stain of the osteoid rim and graft material: A = original magnification x20; B = original magnification x100. 
Red osteoid rim (yellow arrows) green viable bone (blue arrows) and graft material (red arrows).
Figure 12. Trichrome stain of osteoid (original magnification x40). Red osteoid rim (yellow arrows) green viable bone (blue arrows) and 
graft material (red arrows).
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RESULTS
Clinical results
No complications, including wound dehiscence, 
were observed in any of the patients. One of the 42 
implants was removed between implantation and 
the follow-up period. This implant was successful ly 
restored by wider diameter implant. The 0 to 6 month 
cumulative implant survival rate was 97.6 %, and this 
value continued to 36 months.
Radiographic results
The mean follow-up period for implants after the 
sinus augmentation was 28.4 (3.2) months (range 
24 to 36 months). The original sinus height was a 
mean of 3.65 (0.7) mm (range 1.4 to 4.6 mm) and 
the augmented sinus height was a mean of 13.8 (2.4) 
mm (range 9.5 to 16.7 mm) after the surgery. The 
mean implant marginal bone loss up to 30 months 
after loading was 0.38 (0.24) mm. The RDL 1 year 
postoperatively was 0.83 (0.38) mm, and at 3 years 
postoperatively was 0.91 (0.25) mm. No significant 
correlation was noted between the RDL and follow-
up periods by Spearman’s test (P = 0.118). In addition, 
no significant differ ence in the RDL was observed 
according to the site of im plantation (P = 0.682).
Histologic and histomorphometric results
Microscopic examination of all the processed bone 
core specimens showed newly formed bone, in 
close contact with the xenogenic graft particles. No 
gaps were found at the bone-graft interface. Most 
of the graft particles were surrounded by newly 
formed bone, and in some areas, the graft particles 
were in contact with marrow spaces. The presence 
of non-mineralized matrix (osteoid seam) was also 
observed at the interface with the xenograft, which 
was strongly stained by Von Kossa; the osteoid was 
surfaced by a rim of osteoblasts (Figures 11 and 12). 
The newly formed bone abutting the graft particles 
showed well-organized lamellae, and numerous 
lacunae with osteocytes. No acute inflammatory 
infiltrate or foreign body granulomatous tissue was 
evident. Histomorphometric analysis showed the 
bone cores were composed of 64.72 (3.44)% newly 
formed bone, 17.41 (2.02)% connective tissue, 16.93 
(2.83)% residual graft particles, and 0.94 (0.11)% 
inflammatory cells. Histomorphometric mean data are 
reported in Table l.
Table 1. Histomorphometric mean data of bone core specimens
Bone core SD
Tt. tissue area (mm2) 12.01 1.9
Tt. area of bone (mm2) 7.31 0.8
Tt. area of bone graft (mm2) 1.85 0.3
% connective tissue/Tt. area 17.41 2.02
% bone/Tt. tissue area 64.72 3.44
% graft/Tt. tissue area 16.93 2.83
Tt. osteoid area (mm2) 0.017 0.004
Tt. connective tissue area (mm2) 0.647 0.194
Tt. bone marrow area (mm2) 1.323 0.332
Tt. bone surface (mm) 84.87 9.81
Tt. osteoid surface (mm) 1.791 0.64
% osteoid/Tt. bone surface 2.16 0.72
Trabecular thickness (um) 170.03 18.5
Trabecular number (mm-1) 3.583 0.74
Trabecular space (um) 102.8 21.3
% inflammatory cells/Tt. tissue area 0.94 0.11
SD = standard deviation; Tt. = total biopsy core.
DISCUSSION
Technological evolution and better understanding 
of bone-healing biology have helped to clarify the 
optimum makeup of xenogenic bone substitute, 
including the source, preparation methods, 
and particle size, in order to improve their 
osteoconductive potential. When associated with 
the refinement of the sinus lift surgical technique 
occurred in recent years, this allows for predictable 
placement of implants in atrophic maxillae bone 
regenerated with xenografts [10,25,26]. In the 
present study, the survival rate of implants placed 
after a sinus augmentation procedure was 97.6 %, 
which is comparable with the pre-existing literature 
data [25,27-29] despite the small sample size. In 
addition, radiographic evaluation showed the graft 
material, was well maintained in the sinus and only 
decreased slightly over a 3 year period, demonstrating 
that Laddec® is a clinically suitable material for 
sinus augmentation. Despite the clinical success of 
xenogenic graft materials, few histomorphometric 
studies are reported in the published literature [30,31]. 
The purpose of our histologic and histomorphometric 
evaluation is to understand the interactions that occur 
between the bone and the graft. In all the histological 
sections examined in the present study, no evidence 
of acute inflammatory infiltrate, or foreign body 
granulomatous tissue was found. This indicates 
that the processing methodology of Laddec® is safe, 
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as the biomaterial does not induce adverse 
immunologic response. In addition, the regenerated 
bone has shown that Laddec®, is mostly reabsorbed 
after 6 months, replaced by vital bone, and the 
residual xenograft particles are integrated to vital 
bone. Histological analysis showed the bone cores 
were composed of 64.72 (3.44)% newly formed 
bone, 17.41 (2.02)% connective tissue, 16.93 
(2.83)% residual graft particles, and 0.94 (0.11)% 
inflammatory cells. The 16.93% residual graft 
particles indicate that, after 6 months, the graft 
material is almost all reabsorbed and replaced by 
newly regenerated bone. These data are particularly 
significant because it is known that to maintain the 
osseointegration of the implant over the time, a 
presence of reactive tissue able to undergo a sustained 
state of remodelling is needed [32]. Several studies 
have suggested that differing methods of xenograft 
preparation can cause differences in efficacy [33,34] 
and in reabsorption time [9,35,36]. Orsini et al. [3] 
reported that bovine bone derived graft material in 
which all the organic phase is chemically removed 
(Bio-Oss®) after 6 months does not show signs 
of resorption. Same authors reported identical 
histological results also for porcine derived bone 
substitute with no evidence at 6 months of biomaterial 
resorption [36]. In our opinion, the differences 
between the histologic results of the present study and 
those reported by these other studies might be related 
to the specific chemical/physical features of the graft 
materials, and the events occurring after biomaterial 
implantation. When a graft material is implanted in 
bone, the healing process is characterized by two 
phases: 1) the response of the host to the biomaterial; 
and 2) the behaviour of the material in the host 
[37,38]. A non-specific action occurs in the first 
phase: a blood clot is formed in the injured area where 
the outer area of the local bone becomes necrotic, 
the capillaries start to develop, and migration of 
inflammatory cells e.g. lymphocytes, granulocytes and 
monocytes occurs. These actions restore blood flow, 
activate an inflammatory response after 1 - 3 days, and 
start to form granulation tissue. The granulation tissue 
will mature to a collagen matrix and mesenchymal 
stem cells begin to differentiate into osteoblasts 
cells. A more specific action occurs during the 
second phase depending on the ability of osteoblastic 
cells to migrate into the biomaterial and on the 
relationships they establish between their membrane 
and the biomaterial surface. Adhesion, proliferation, 
migration, and differentiation of mesenchymal 
stem cells at the surface of grafted materials 
are related to the ability of membrane receptors 
to bind molecules of the extracellular matrix. 
Among the membrane receptors, integrins are 
transmembrane αβ heterodimer proteins known to 
play a key role in the cellular adhesion [39-41]. In 
bone, the b1-integrin subunit is shared by several 
integrins in osteoblasts [42-45]. Specifically, the 
b1-subunit is involved in adhesion of osteoblasts 
to collagen type I and is supposed to play a role in 
osteoblast morphology. Previous in vitro studies 
highlighted the importance of preserving the collagen 
matrix in the xenograft material [19,20]. Comparing 
two different types of bovine derived bone graft 
materials, with similar architectural organization, 
morphological surface topography and roughness 
index, but with different chemical composition of 
their matrices, (Laddec® characterized by preservation 
of the mineralized collagen matrix, and Bio-Oss®, 
characterized by complete deproteinization which 
only preserves the mineral phase), Balsè et al. [19] 
reported that osteoblast-like cells cultured at the 
surface of the two bone xenogenic biomaterials have 
their orientation mainly influenced by the chemical 
nature of the underlying surface. At the surface of the 
collagen-containing matrix (Laddec®), cells exhibited 
an elongated shape and oriented axis parallel to 
the underlying collagen bundles. In contrast, at the 
surface of the single mineral matrix (Bio-Oss®), cells 
were round shaped with random disposition. The 
b1-integrin subunit, detected with an immunogold 
method at the transmission electron microscopic 
level, was found localized at the outer surface of 
cells, in close association with mineralized collagen 
matrix, and at the contact points between cells and 
biomaterials. In contrast, at the surface of the single 
mineral matrix (Bio-Oss®), cells were round-shaped 
with random disposition and without association with 
deproteinized matrix. The importance of preserving 
the collagen matrix in the xenograft material, has 
also been reported by another in vitro study [22], in 
which authors reported that mesenchymal stem cells, 
growing on the highly purified bovine xenograft 
granules, exhibit a high seeding efficiency, a good 
proliferation, and an early expression of membrane 
(vesicles) specializations, presumably due to the 
process of mineralisation since X-ray microanalysis 
showed the presence of calcium. Although in vitro 
studies must be interpreted with caution since they 
cannot recreate the complex interactions of cells in 
vivo, those studies indicated the presence of collagen 
fibres in the matrix of a bone xenogenic biomaterial 
appears to be the major element in determining early 
cell disposition, and perhaps further cell functions 
such as orientation of new matrix deposition. 
Histomorphometric analysis in the present study add 
further information for understanding the Laddec® 
http://www.ejomr.org/JOMR/archives/2016/1/e3/v7n1e3ht.htm J Oral Maxillofac Res 2016 (Jan-Mar) | vol. 7 | No 1 | e3 | p.9
(page number not for citation purposes)
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                              Guarnieri et al.
xenograft integration process in the bone site, and 
interactions that occured seem to sustain the validity 
of previously reported data. However, further study 
and additional long-term histologic analyses are 
needed to confirm our results.
CONCLUSIONS
Within the limitation of the present study, it can be 
suggested that the highly purified xenogenic bone 
substitute Laddec® may have predictable results 
when used as a grafting material for maxillary sinus 
lift procedures due to its excellent osteoconductive 
properties. 
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